PTGX Past Earnings image   This PTGX past earnings page last updated 5/9/2024
PTGX Past Earnings
PeriodPast Earnings DateGAAP
Q1 20245/7/20243.260
Q4 20232/27/20240.440
Q3 202311/2/2023-0.580
Q2 20238/3/2023-0.680
Q1 20235/4/2023-0.670
Q4 20223/15/2023-0.690
Q3 202211/8/2022-0.640
Q2 20228/4/2022-0.840
Q1 20225/4/2022-0.430
Q4 20212/28/2022-0.770
Q3 202111/3/2021-0.700
Q2 20218/4/2021-0.690
Q1 20215/4/2021-0.540
Q4 20203/10/2021-0.480
Q3 202011/4/2020-0.210
Q2 20208/6/2020-0.590
Q1 20205/7/2020-0.720
Q4 20193/10/2020-0.630
Q3 201911/6/2019-0.610
Q2 20198/7/2019-1.180
Q1 20195/8/2019-0.580
Q4 20183/12/2019-0.57
Q3 201811/6/2018-0.38
Q2 20188/7/2018-0.41
Q1 20185/9/2018-0.36
Q4 20173/7/2018-0.15
Q3 201711/6/2017-0.29
Q2 20178/8/2017-0.89
Q1 20175/10/2017-0.84
Q4 20163/7/2017-0.67
Q3 201611/14/2016-0.87
PTGX Past Revenue
PeriodPast Earnings DateGAAP
Q1 20245/7/20240.25B
Q4 20232/27/20240.06B
Q3 202311/2/2023NA
Q2 20238/3/2023NA
Q1 20235/4/2023NA
Q4 20223/15/2023NA
Q3 202211/8/2022NA
Q2 20228/4/20220.00B
Q1 20225/4/20220.03B
Q4 20212/28/20220.01B
Q3 202111/3/20210.01B
Q2 20218/4/20210.00B
Q1 20215/4/20210.01B
Q4 20203/10/20210.01B
Q3 202011/4/20200.01B
Q2 20208/6/20200.01B
Q1 20205/7/20200.00B
Q4 20193/10/20200.00B
Q3 201911/6/20190.00B
Q2 20198/7/2019-0.01B
Q1 20195/8/20190.00B
Q4 20183/12/20192.35M
Q3 201811/6/20186.12M
Q2 20188/7/201811.67M
Q1 20185/9/201810.78M
Q4 20173/7/201811.28M
Q3 201711/6/20178.78M
Q2 20178/8/2017NA
Q1 20175/10/2017NA
Q4 20163/7/2017NA
Q3 201611/14/2016NA
Quotes delayed 20 minutes

Email EnvelopeFree PTGX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Protagonist Therapeutics (PTGX) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

PTIX Past Earnings
PTPI Past Earnings
PULM Past Earnings
PYXS Past Earnings
QDEL Past Earnings
QLGN Past Earnings
QNCX Past Earnings
QTRX Past Earnings
RAIN Past Earnings
RANI Past Earnings

PTGX Past Earnings Q&A

What was the best and worst PTGX past earnings results?
For Protagonist Therapeutics, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest PTGX past earnings result in our data set was 3.260/share posted in Q1 2024, while the lowest was in Q2 2019 when PTGX posted -1.180/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q1 2024 when PTGX reported 0.25B in revenue, while the quarter with the lowest revenue in our data set was Q2 2019 at -0.01B of revenue.

  Suggested answer: There are 31 PTGX past earnings results in our data set.

On this page we presented the PTGX past earnings date information for Protagonist Therapeutics. Reviewing that PTGX Past Earnings for the company, we see that the highest past earnings result in our data set was in Q1 2024, when PTGX posted gaap of 3.260/share. Meanwhile the lowest PTGX past earnings result was in Q2 2019, when PTGX posted gaap of -1.180/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q1 2024 when PTGX reported 0.25B in revenue, while the smallest revenue quarter was Q2 2019 when PTGX reported -0.01B in revenue.

Any self directed investor doing their due diligence on PTGX or any other given stock can benefit from researching all of the Protagonist Therapeutics past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you to make it easy for investors to investigate Protagonist Therapeutics past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for PTGX. Thanks for visiting, and the next time you need to research PTGX past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: FCF Videos, GNC Insider Buying, SDRL Split History.


PTGX Past Earnings | | Copyright © 2020 - 2024, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
Wait! Don't leave yet.
Want to receive our latest research absolutely free?

Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.